Madrigal制药 MDGL 深 沪
已收盘 09-20 16:00:00 美东时间
233.49
-8.760
-3.62%
华盛通- 最 高244.225
- 今 开243.47
- 成交量 53.00万股
- 最 低 233.00
- 昨 收 242.25
- 总市值 46.46亿
- 52周最高 299.98
- 市盈率 静 --
- 换手率 2.66%
- 52周最低 119.7604
- 委 比 6.67%
- 总股本 1989.74万
- 历史最高 415.80
- 量 比 2.49
- 振 幅 4.63%
- 历史最低 5.25
- 每 手 1
- 风险率 43.95%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多These are the stocks with the largest changes in short interest in July - GS
Goldman Sachs analysts listed the top 20 stocks with the largest increases and the largest decreases in short interest as of July 31. These are Russell 3000 (NYSEARCA:IWV) stocks with market capitaliz...
08-22 02:51
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. ...
08-13 01:35
When Will Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Breakeven?
With the business potentially at an important milestone, we thought we'd take a...
08-09 20:17
Evercore ISI Group Maintains Outperform on Madrigal Pharmaceuticals, Lowers Price Target to $360
Evercore ISI Group analyst Liisa Bayko maintains Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Outperform and lowers the price target from $405 to $360.
08-08 21:09
快讯 | Madrigal Pharmaceuticals公司: Evercore ISI将目标价从$405降至$360
Madrigal Pharmaceuticals Inc : Evercore ISI Cuts Target Price to $360 From $405
08-08 17:00
Madrigal falls despite massive Q2 revenue beat
Madrigal Pharmaceuticals (NASDAQ:MDGL) lost over 12%, marking its biggest intraday drop in more than a year, as Wall Street reacted to the company’s Q2 2024 revenue, which, however, exceeded forecasts...
08-07 22:58
Madrigal Pharmaceuticals shares are trading lower. The company reported Q2 financial results.
Madrigal Pharmaceuticals shares are trading lower. The company reported Q2 fina...
08-07 22:22
快讯 | Madrigal pharmaceuticals报告2024年第二季度财务业绩并提供企业更新。
Madrigal Pharmaceuticals Reports Second-Quarter 2024 Financial Results and Prov...
08-07 19:00
快讯 | Madrigal Pharmaceuticals任命Shannon Kelley为法律总顾问。
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
08-02 19:00
Cantor Fitzgerald Reiterates Neutral on Madrigal Pharmaceuticals
Cantor Fitzgerald analyst Prakhar Agrawal reiterates Madrigal Pharmaceuticals (NASDAQ:MDGL) with a Neutral.
07-23 20:09
